AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
NYSTATIN BP
10 registrations across 3 African markets— 6 active
Markets with NYSTATIN BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Dawastin suspension Suspension for Oral Use | 🇿🇲Zambia | Dawa Limited | active | Aug 2030 |
| NYSTATIN TABLETS Tablets | 🇷🇼Rwanda | MERIT ORGANICS LTD | active | Aug 2029 |
| DAWASTIN ORAL SUSPENSION Suspension | 🇷🇼Rwanda | DAWA LIMITED | active | Aug 2029 |
| GYNASTATIN BP VAGINAL PESSARIES | 🇷🇼Rwanda | BLISS GVS PHARMA LIMITED | active | Aug 2029 |
| NYSKA-P Suspension | 🇷🇼Rwanda | S KANT HEALTHCARE LTD | active | Aug 2029 |
| MYCOREN SUSPENSION SUSPENSION | 🇷🇼Rwanda | RENE INDUSTRIES LTD | active | Jul 2029 |
| MYCONOVA 100 000IU/ML SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2025 |
| DAWASTIN 100 000IU SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2025 |
| NYSTATIN 100000 IU ORAL SUSPENSION ORAL SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2019 |
| NYSTEC 100,000IU ORAL SUSPENSION ORAL SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2010 |
NYSTATIN BP in Africa — Regulatory Overview
NYSTATIN BP is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Rwanda, Malawi, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 6 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.